Healios KK

As of June 30, 2026, Healios KK carries a market capitalization of 34.16B, placing it among publicly traded companies globally. Its enterprise value stands at 25.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Healios KK's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Healios KK has 135.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Healios KK maintains a current ratio of 2.05, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Healios KK's stock has declined approximately 45.44% over the past 52 weeks. The 50-day moving average sits at 283.60, while the 200-day moving average is 316.85.

As of June 30, 2026, Healios KK holds 10.87B in cash and equivalents against 2.59B in total debt, resulting in a net debt position of -8.82B. Total book value stands at 7.55B, with working capital of 6.05B providing operational flexibility.